More than one Chinese mole has infiltrated our research centers “many of whom have become U.S. citizens, have remained loyal to the Chinese Communist Party and are actively collaborating with their counterparts in China, including the People’s Liberation Army.” Xiaoyuan Chen is the latest to be caught in the trap.
Another mole on the payroll
The Gateway Pundit is convinced that America’s medical research labs are “little more than Chinese colonies, extensions of China’s fused military-civilian research programs and fully funded by the U.S. taxpayer.”
They have evidence to back that up, too. Take, for example, the case of a mole tunneling deep into Dr. Anthony Fauci’s National Institutes of Health.
For a full eleven years, between 2009 and 2020, “Dr. Xiaoyuan (Shawn) Chen worked at the National Institutes of Health, eventually rising to become Chief of the Laboratory of Molecular Imaging and Nanomedicine at the National Institute of Biomedical Imaging and Bioengineering.”
The mole raked in a salary by the U.S. federal government and also “received in excess of $38 million in NIH research funding.”
Nobody suspected, in all that time, that he was a mole. Chen kept his “parallel career” totally secret, “working with China’s People’s Liberation Army and establishing a mirror-image of his NIH research activities in Xiamen University in China.”
Not reporting that is “violation of U.S. government protocol if not U.S. law.” Along with his U.S. research, Chen became a rather prolific author, writing in Chinese for the PLA.
PLA his co-author
In 2011 the energetic mole published “PET of Insulinoma using 18F-FBEM-EM3106B, a New GLP-1 Analog” under his own name, listing the People’s Liberation Army’s Fourth Military Medical University in Xi’an, China, as “co-author.”
It mirrored his official American work “supported by the Intramural Research Program of the National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health.” He was paid for the work by Uncle Sam, then sold it again to Xi Jinping.
Two years later, in 2013 Xi’s pet mole published another one with the same co-author this one carries the heavy duty title, “Noninvasive Visualization of MicroRNA-16 in the Chemoresistance of Gastric Cancer Using a Dual Reporter Gene Imaging System.”
For some strange reason it “does not appear in the NIH publication record for Xiaoyuan Chen.” Neither does their next production from 2016, “Multimodal-Imaging-Guided Cancer Phototherapy by Versatile Biomimetic Theranostics with UV and γ-Irradiation Protection.”
That one doesn’t show up even though “the article states that the research was supported by the Intramural Research Program.” In 2018, the mole did it again with “Hierarchical Tumor Microenvironment-Responsive Nanomedicine for Programmed Delivery of Chemotherapeutics.”
Again, it lists the U.S. sponsorship but doesn’t appear in his official list of work, and has the same Chinese Army co-author as the rest. By 2020 he was working on “Ultra-small copper-based nanoparticles for reactive oxygen species scavenging and alleviation of inflammation related diseases.”
